Condition: Cervical Cancer · Cervical Dysplasia · Oropharyngeal Cancer · Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.
This description comes directly from the study's public registry record.
Marian Hajduch, MD., PhD. · +420 585 632 083 · marian.hajduch@upol.cz
Vladimira Koudelakova, MSc, Ph.D. · +420 585 632 089 · vladimira.koudelakova@upol.cz
Always discuss trial participation with your own doctor first.
| University Hospital Olomouc | Olomouc, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05774561